May IgG4-related disease be reactivated by SARS-CoV-2 infection?

Abstract

Patients with inflammatory rheumatic diseases are at high risk for severe outcomes associated with coronavirus disease 2019 (COVID-19) due to the immune disturbances related to the disease, administration of immuno- suppressive drugs and comorbidities [1, 2].